Other Guidelines | Page 3 | European Cystic Fibrosis Society (ECFS)

Early signs of Cystic Fibrosis Related Diabetes (CFRD) and low amount of the neuropeptide VIP in ΔF508-CF mice.

“Coping and Learning to Manage Stress with CF” a Telehealth Pilot Intervention

The influence of cystic fibrosis on work ability of affected patients

Clofazimine use for treatment of mycobacteria in children with and without cystic fibrosis

Stopping exposure to smoke improves breathing and nutritional outcomes in children and adolescents with cystic fibrosis

Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis

Do bone active therapy and lung disease influence the skeletal outcome after transplantation?

Using an Antibiotic Treatment Called Amikacin Liposome Inhalation Suspension (or ALIS) for Chronic Infection With Pseudomonas aeruginosa in People With Cystic Fibrosis for 2 years

Orkambi may improve liver disease in people with CF

Review of pregnancy in cystic fibrosis

first
previous
1
2
3
4
5
6
7
8
9
…
next
last